TDM Menu Expansion

About BUHLMANN Diagnostics

BUHLMANN Diagnostics Corp is a U.S.-based provider of specialized diagnostic assays, serving as the commercial arm for the Swiss parent company BÜHLMANN Laboratories AG. The company has established a strong niche in gastrointestinal diagnostics, particularly with its BÜHLMANN fCAL® calprotectin assays, which are a gold standard for monitoring IBD. Its portfolio extends into allergy testing, neuroimmunology, and therapeutic drug monitoring, supported by proprietary technologies like the Quantum Blue® point-of-care platform and CALEX® Cap sample extraction system. As a private company, it leverages its parent's long-term R&D and manufacturing expertise to serve clinical and research laboratories in North America.

Therapeutic Areas